Skip to main content
AVTRAvantor, Inc.Sell5.2·$16.69
SellModerate Confidence
Investment thesis

Quality well below the minimum threshold and a confirmed technical downtrend—reinforced by a death cross hard block—combine to create a risk/reward of roughly 0.21 to 1, leaving this setup with more downside exposure than upside potential at current prices.

Thesis pillars

  • Quality Below Minimum Floor→Stable
  • Confirmed Downtrend Death Cross Block↓Deteriorating
  • Elevated Put Call Bearish Positioning→Stable
  • +2 more pillars — see the Why tab for full reasoning

Pillars as of Jul 3, 2026, based on the 10-K filed Feb 11, 2026

Full reasoning →

Open full analysis

Avantor, Inc. (AVTR) Stock Analysis

Breakout setup

SellGrowthModerate Confidence

Healthcare · Medical Instruments & Supplies

Sell if holding. Engine safety override at $16.69: a dimension score below its floor triggers a hard block regardless of the otherwise-positive setup — overall score 5.2/10. Specifically: Elevated put/call ratio: 2.20; Below-average business quality.

Avantor distributes laboratory supplies and manufactures specialty materials — J.T. Baker high-purity chemicals, NuSil silicone, and Masterflex fluid systems — to 300,000+ customer locations in ~180 countries through Laboratory Solutions and Bioscience Production segments. The... Read more

$16.69-16.8% A.UpsideScore 5.2/10#19 of 29 Medical Instruments & Supplies
QualityF-score9 / 9FCF yield3.99%
Stop $15.69Analyst target $13.89(reached)A.R:R -1.3:1
Analyst consensus$15.96-4.4%13 analysts
$16.69price
$15.96mean
$13
$19

Sell if holding. Engine safety override at $16.69: a dimension score below its floor triggers a hard block regardless of the otherwise-positive setup — overall score 5.2/10. Specifically: Elevated put/call ratio: 2.20; Below-average business quality. Chart setup: Golden cross, above all MAs, RSI 69, MACD bullish. Score 5.2/10, moderate confidence.

Passes 6/8 gates (positive momentum, clean insider activity, news boost earnings 0.60, earnings proximity no date, semi cycle peak clear, materials cycle peak clear). Fails on favorable risk/reward ratio. Suitability: moderate.

news + 30-day 8-K events · 5-min refresh

Recent developments

updated 2026-10-29

Recent Developments — Avantor, Inc.

Generated 2026-10-29T11:14:31Z.

TrendMatrix Research · upcoming catalyst calendar

Upcoming dated catalysts

Wed, Oct 28, 2026Date unconfirmed· next earnings call

Thesis

Rewards
Recent Earnings detected in news
Risks
Concentration risk — Supplier: sole-sourced raw materials
Target reached (-16.8% upside)
Quality below floor (3.4 < 4.0)

Key Metrics

P/E (TTM)33.4
P/E (Fwd)19.0
Mkt Cap$11.3B
EV/EBITDA15.9
Profit Mgn-8.8%
ROE-9.7%
Rev Growth0.5%
Beta0.94
DividendNone
Rating analysts24

Quality Signals

Piotroski F9/9

Options Flow

P/C2.20bearish
IV67%elevated

Concentration Risks(10-K Item 1A)

  • HIGHSuppliersole-sourced raw materials
    10-K Item 1A: 'raw materials, many of which are sole-sourced due to market or customer demands'

Material Events(8-K, last 90d)

  • 2026-04-01Item 5.02HIGH
    CFO R. Brent Jones resigned March 26, 2026 to join a company outside life sciences (90-day notice required). SVP/CAO Steven Eck named interim CFO; executive search for permanent CFO underway. No permanent successor named.
    SEC filing →
  • 2026-04-23Item 5.02MEDIUM
    EVP Benoit Gourdier notified April 17, 2026 of transition to segment integration role, expected to depart by Dec 31, 2026. Successor Ludovic Brellier named EVP Bioscience and Medtech Products and Chief Transformation Officer, effective May 1, 2026.
    SEC filing →

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Editorial policy

Show full disclosure ▾

About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.

Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.

Conflicts and positions. People who build TrendMatrix, or entities they control, may hold positions, long or short, in securities it covers, and may trade them at any time. Positions are not disclosed individually. Verdicts are generated by an automated model applied by the same rules to every covered stock, and are not adjusted for any position held by the people who build TrendMatrix. We do not accept payment from issuers for coverage.

No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security.

No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.

Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.

Methodology · Editorial policy & full disclaimer

Rating Breakdown

2 floor-breakers

Ranks in the bottom of its industry peers on the composite signal. Better names in the same sector exist.static

Growth Rank
0.4
Quality Rank
2.0
Value Rank
6.6

Unprofitable operations — net margin -8.8%. Quality floor flags this regardless of sector context.static

Roe
0.0
Net Margin
0.0
Roa
1.8
Gross Margin
2.4
Operating Margin
2.9
Moat
3.9
Current Ratio
6.3
Piotroski F
10.0
No competitive moatStrong Piotroski F-Score: 9/9
GatesA.R:R -1.3=NEGATIVEExecutive change: officer departure/appointmentMomentum 5.8>=5.5Insider activity: OKNEWS BOOST EARNINGS 0.60EARNINGS PROXIMITY NO DATESEMI CYCLE PEAK CLEARMATERIALS CYCLE PEAK CLEARBreakoutSuitability: Moderate
RSI
69 · Neutral
↑ 20D MA↑ 50D MA↑ 200D MAGOLDEN CROSSSupport $14.57Resistance $17.45

Price Targets

A.Upside-16.8%
A.R:R-1.3:1

Position Sizing

ConvictionNone
Suggested %0%
Max %0%
RegimeSteady

Risk Alerts

! Target reached (-16.8% upside)
! Quality below floor (3.4 < 4.0)
! Negative risk/reward — downside exceeds upside

Earnings

B
B
B
M
3/4 beats
Next Earnings2026-10-28 (Date unconfirmed)

Verdict History

reverse chrono — latest first
Loading history...
Verdicts are recorded on every nightly pipeline run. Rows capture transitions (verdict flips, score deltas ≥0.3, entry/TP/SL changes). Rows with a ▶ can be expanded to see the change reason. Aggregate cohort performance is tracked in the recommendation ledger.
Frequently Asked Questions
Is AVTR stock a buy right now?

Sell if holding. Engine safety override at $16.69: a dimension score below its floor triggers a hard block regardless of the otherwise-positive setup — overall score 5.2/10. Specifically: Elevated put/call ratio: 2.20; Below-average business quality. Chart setup: Golden cross, above all MAs, RSI 69, MACD bullish. Prior stop was $15.69. Score 5.2/10, moderate confidence.

What is the AVTR stock price target?

Analyst target $13.89 reached (−16.8% from $16.69); no take-profit level is published. Prior stop was $15.69. Stop-loss: $15.69.

What are the risks of investing in AVTR?

Concentration risk — Supplier: sole-sourced raw materials; Target reached (-16.8% upside); Quality below floor (3.4 < 4.0).

Is AVTR overvalued or undervalued?

Avantor, Inc. trades at a P/E of 33.4 (forward 19.0). TrendMatrix value score: 6.0/10. Verdict: Sell.

What do analysts say about AVTR?

24 analysts cover AVTR with a consensus score of 3.4/5. Average price target: $16.

What does Avantor, Inc. do?Avantor distributes laboratory supplies and manufactures specialty materials — J.T. Baker high-purity chemicals, NuSil...

Avantor distributes laboratory supplies and manufactures specialty materials — J.T. Baker high-purity chemicals, NuSil silicone, and Masterflex fluid systems — to 300,000+ customer locations in ~180 countries through Laboratory Solutions and Bioscience Production segments. The company generates revenue through distribution and service contracts, with ~80% of 2025 transactions via digital channels and no single customer exceeding 5% of net sales.

Related stocks: STAA (STAAR Surgical Company) · TFX (Teleflex Incorporated) · NVST (Envista Holdings Corporation) · MMED (MiniMed Group, Inc.) · WST (West Pharmaceutical Services, I)
Home › Stocks › AVTR

Latest news

Latest News

Benzinga14m ago
Benzinga22h agoEarnings
Fiscal.ai1d ago
Benzinga1d ago
Benzinga1d agoEarnings
Fiscal.ai3d agoLeadership Change
Benzinga16d agoAnalyst
Benzinga16d agoAnalyst
Benzinga22d agoAnalyst
Benzinga29d ago
Benzinga38d agoRestructuring
Benzinga50d agoAnalyst
Benzinga91d agoAnalyst
Benzinga91d agoAnalyst
Benzinga91d agoAnalyst
Benzinga91d agoAnalyst
Benzinga92d ago
Benzinga92d ago
Benzinga92d agoEarnings
Benzinga92d agoEarnings
Loading more...